ATE232397T1 - Neuartige orale zubereitungen von calcitonin - Google Patents

Neuartige orale zubereitungen von calcitonin

Info

Publication number
ATE232397T1
ATE232397T1 AT97950098T AT97950098T ATE232397T1 AT E232397 T1 ATE232397 T1 AT E232397T1 AT 97950098 T AT97950098 T AT 97950098T AT 97950098 T AT97950098 T AT 97950098T AT E232397 T1 ATE232397 T1 AT E232397T1
Authority
AT
Austria
Prior art keywords
calcitonin
oral preparations
novel oral
novel
preparations
Prior art date
Application number
AT97950098T
Other languages
English (en)
Inventor
Matteo Ghirri
Marco Zema
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Application granted granted Critical
Publication of ATE232397T1 publication Critical patent/ATE232397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT97950098T 1996-11-07 1997-11-05 Neuartige orale zubereitungen von calcitonin ATE232397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9623205.3A GB9623205D0 (en) 1996-11-07 1996-11-07 Novel pharmaceutical compositions
PCT/EP1997/006104 WO1998019697A2 (en) 1996-11-07 1997-11-05 Novel pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE232397T1 true ATE232397T1 (de) 2003-02-15

Family

ID=10802593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950098T ATE232397T1 (de) 1996-11-07 1997-11-05 Neuartige orale zubereitungen von calcitonin

Country Status (15)

Country Link
US (1) US6352974B1 (de)
EP (1) EP0966299B1 (de)
JP (1) JP2001511114A (de)
AR (1) AR010554A1 (de)
AT (1) ATE232397T1 (de)
AU (1) AU5317598A (de)
CA (1) CA2270927A1 (de)
CO (1) CO4930284A1 (de)
DE (1) DE69719083T2 (de)
DK (1) DK0966299T3 (de)
ES (1) ES2192704T3 (de)
GB (1) GB9623205D0 (de)
PT (1) PT966299E (de)
WO (1) WO1998019697A2 (de)
ZA (1) ZA9710006B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
AU2001259063A1 (en) * 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
BRPI0412265A (pt) * 2003-07-23 2006-09-05 Novartis Ag uso de calcitonina em osteoartrite
JP2008509933A (ja) * 2004-08-13 2008-04-03 エミスフェアー・テクノロジーズ・インク 送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
AU2006236006B2 (en) * 2006-04-13 2012-09-06 The University Of Queensland Cyclised a-conotoxin peptides
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
WO2008102264A2 (en) * 2007-02-20 2008-08-28 Eurand Pharmaceuticals Limited Stable digestive enzyme compositions
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
CL2011002432A1 (es) 2010-10-01 2012-04-20 Aptalis Pharma Ltd Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
ES2734221T3 (es) 2011-08-08 2019-12-04 Allergan Pharmaceuticals Int Ltd Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
JP2016537387A (ja) 2013-08-09 2016-12-01 アラガン ファーマシューティカルズ インターナショナル リミテッド 経腸投与に適した消化酵素組成物
MX2016016907A (es) 2014-06-19 2018-04-26 Aptalis Pharma Ltd Metodo para eliminar contaminantes virales de extractos pancreaticos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤

Also Published As

Publication number Publication date
PT966299E (pt) 2003-06-30
DE69719083D1 (de) 2003-03-20
CO4930284A1 (es) 2000-06-27
JP2001511114A (ja) 2001-08-07
EP0966299A2 (de) 1999-12-29
DE69719083T2 (de) 2003-12-18
ZA9710006B (en) 1999-06-05
CA2270927A1 (en) 1998-05-14
EP0966299B1 (de) 2003-02-12
WO1998019697A3 (en) 1998-07-16
GB9623205D0 (en) 1997-01-08
AU5317598A (en) 1998-05-29
DK0966299T3 (da) 2003-06-02
ES2192704T3 (es) 2003-10-16
WO1998019697A2 (en) 1998-05-14
AR010554A1 (es) 2000-06-28
US6352974B1 (en) 2002-03-05

Similar Documents

Publication Publication Date Title
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
DE69429359T2 (de) Orale zubereitungen von antimykotika
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DE69833739D1 (de) Kosmetisches Präparat
DE69518331D1 (de) Orale zubereitungen
KR950703926A (ko) 화장제 조성물(Cosmetic Composition)
DE69625368T2 (de) Schweisshemmende deodorierende präparaten
DE69329764T2 (de) Neues kosmetisches präparat
DE69528131T2 (de) Kosmetische Präparate
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ATE176383T1 (de) Dermal applizierbare formulierungen von parasitiziden
DE59710701D1 (de) Kosmetische zubereitungen
DE69804630D1 (de) Reindarstellung von propylenoxid
DE69415340D1 (de) Kosmetisches präparat
DE59804418D1 (de) Kosmetische zubereitungen
DE69719083D1 (de) Neuartige orale Zubereitungen von Calcitonin
KR970000228A (ko) S-에토돌락의 경구용 제제
DE59709718D1 (de) Kosmetische zubereitungen
DE69518464T2 (de) Verdickte kosmetische Zubereitungen
DE59707298D1 (de) Desodorierende zubereitungen
DE69432149T2 (de) Orale Zubereitungen
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
DE69737529D1 (de) Herstellung von 1-butyl-4-piperidinylmethylamin
DE59707043D1 (de) Kosmetische Zubereitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0966299

Country of ref document: EP

REN Ceased due to non-payment of the annual fee